AMERICAN NET PRESTIGE

Brand	Owner	Address	Description
AMERINET PRESTIGE	AMERINET, INC.	Box 46930 2060 Craigshire Road St. Louis MO 63146	AMERICAN NET PRESTIGE; AMERICAN NETWORK PRESTIGE;NEGOTIATION OF COMMERCIAL TRANSACTIONS FOR THIRD PARTIES, NAMELY, SERVICES RELATING TO THE NEGOTIATION OF GROUP PURCHASING CONTRACTS, NAMELY, PROCURING OF CONTRACTS FOR THE PURCHASE OF MEDICAL AND SURGICAL SUPPLIES, PHARMACEUTICALS, LABORATORY SUPPLIES, MEDICAL EQUIPMENT, AND HOSPITAL EQUIPMENT ON BEHALF OF MEMBER HOSPITALS, CLINICS, SURGERY CENTERS, CLOSED PHARMACIES, NURSING HOMES, HEALTH CARE CENTERS, RETIREMENT CENTERS, MEDICAL LABORATORIES AND EDUCATIONAL INSTITUTIONS WHO PARTICIPATE AT HIGHER MARKET SHARE LEVELS, AND NEGOTIATION OF COMMERCIAL TRANSACTIONS FOR THIRD PARTIES, NAMELY, NEGOTIATING ADDITIONAL DISCOUNTS AND REBATES IN CONNECTION THEREWITH ON BEHALF OF SUCH MEMBERS;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The invention provides isolated polynucleotide molecules, including plasmids; viral vectors; and transfected host cells that comprise a DNA sequence encoding an infectious RNA sequence encoding a North American PRRS virus; and also North American PRRS viruses encoded thereby. The invention further provides isolated infectious RNA molecules encoding a North American PRRS virus. The invention also provides isolated polynucleotide molecules, infectious RNA molecules, viral vectors, and transfected host cells encoding genetically-modified North American PRRS viruses; and genetically-modified North American PRRS viruses encoded thereby. The invention also provides vaccines comprising such plasmids, RNA molecules, viral vectors, and North American PRRS viruses, and methods of using these vaccines in swine and in other animals. Also provided are isolated polynucleotide molecules, viral vectors, and transfected host cells that comprise a nucleotide sequence encoding a peptide of a North American PRRS virus. These viral vectors and transfected host cell lines are useful in providing peptides to compensate for mutated peptide coding sequences of DNA sequences encoding genetically-modified North American PRRS viruses so that functional virions can be generated.